Charles Sternberg, Associate Editor02.17.22
Neo Medical, a Swiss-based Medtech company developing value-based care solutions in spinal surgery, has closed a $20.6 million financing round featuring Swisscom Ventures as lead investor. The proceeds of this financing round will support the accelerated commercial deployment of Neo Medical ADVISE augmented reality platform for spinal surgery, with a particular focus on the U.S. market.
Speaking about the closing of the $20.6 million round, Vincent Lefauconnier, Neo Medical CEO, explained, “Over the past years, we have pushed our integrated physical platform for spinal surgery to levels never reached before, improving surgical outcomes, streamlining treatment cycles, and reducing environmental impacts, while lowering healthcare costs. Looking forward, we will focus on the commercial deployment of the digital component of our platform with ADVISE, which for the first time brings surgeons real-time augmented reality (AR) visibility for patient specific spinal treatment.”
“We have been deeply impressed with Neo Medical’s management team and their vision to digitalize the spinal surgery space. Swisscom Ventures is very excited to support the company with the roll-out of ADVISE and its expansion in the U.S. market. The company is well positioned to scale up and reinforce its position as a global player,” said Dr. Myoung-Ok Kwon, investment partner, Swisscom Ventures.
ADVISE complements Neo Medical’s existing optimized implants and instruments platform, resulting in a total technology ecosystem, transforming spinal surgery. The company’s complete system of hardware and software technologies supports enhanced outcomes at each stage of the perioperative process: preoperative planning, intraoperative actions, and postoperative recovery.
Lefauconnier added, “Improving surgical systems has benefits far beyond the OR. Our technologies are designed to improve outcomes and impacts at every level, decluttering the OR, cutting time spent in surgery, improving outcomes, lowering costs, and reducing environmental damage through material efficiency. As we continue to expand into the digital space, we seek to deliver a total smart surgery solution for surgeons.”
Speaking about the closing of the $20.6 million round, Vincent Lefauconnier, Neo Medical CEO, explained, “Over the past years, we have pushed our integrated physical platform for spinal surgery to levels never reached before, improving surgical outcomes, streamlining treatment cycles, and reducing environmental impacts, while lowering healthcare costs. Looking forward, we will focus on the commercial deployment of the digital component of our platform with ADVISE, which for the first time brings surgeons real-time augmented reality (AR) visibility for patient specific spinal treatment.”
“We have been deeply impressed with Neo Medical’s management team and their vision to digitalize the spinal surgery space. Swisscom Ventures is very excited to support the company with the roll-out of ADVISE and its expansion in the U.S. market. The company is well positioned to scale up and reinforce its position as a global player,” said Dr. Myoung-Ok Kwon, investment partner, Swisscom Ventures.
ADVISE complements Neo Medical’s existing optimized implants and instruments platform, resulting in a total technology ecosystem, transforming spinal surgery. The company’s complete system of hardware and software technologies supports enhanced outcomes at each stage of the perioperative process: preoperative planning, intraoperative actions, and postoperative recovery.
Lefauconnier added, “Improving surgical systems has benefits far beyond the OR. Our technologies are designed to improve outcomes and impacts at every level, decluttering the OR, cutting time spent in surgery, improving outcomes, lowering costs, and reducing environmental damage through material efficiency. As we continue to expand into the digital space, we seek to deliver a total smart surgery solution for surgeons.”